| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anthony James, Christine James, Thomas Thwaite. The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. Psychiatry research. vol 214. issue 3. 2014-10-10. PMID:24139960. |
as in adult schizophrenia cognition does not appear to be adversely affected in aos following cannabis use. |
2014-10-10 |
2023-08-12 |
Not clear |
| Erica Zamberletti, Sarah Beggiato, Luca Steardo, Pamela Prini, Tiziana Antonelli, Luca Ferraro, Tiziana Rubino, Daniela Parolar. Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats. Neurobiology of disease. vol 63. 2014-09-19. PMID:24200867. |
although several findings indicate an association between adolescent cannabis abuse and the risk to develop schizophrenia later in life, the evidence for a causal relationship is still inconclusive. |
2014-09-19 |
2023-08-12 |
rat |
| János M Réthelyi, Judit Benkovits, István Bitte. Genes and environments in schizophrenia: The different pieces of a manifold puzzle. Neuroscience and biobehavioral reviews. vol 37. issue 10 Pt 1. 2014-09-07. PMID:23628741. |
epidemiologically proven risk factors, such as prenatal infection, obstetric complications, urbanicity, cannabis, and trauma have been demonstrated to interact with genetic risk, giving rise to higher prevalence rates or more severe symptomatology in individuals with direct or indirect genetic predisposition for schizophrenia. |
2014-09-07 |
2023-08-12 |
Not clear |
| Ashley C Proal, Jerry Fleming, Juan A Galvez-Buccollini, Lynn E Delis. A controlled family study of cannabis users with and without psychosis. Schizophrenia research. vol 152. issue 1. 2014-08-29. PMID:24309013. |
several studies suggest a link between adolescent cannabis use and schizophrenia. |
2014-08-29 |
2023-08-12 |
Not clear |
| Ashley C Proal, Jerry Fleming, Juan A Galvez-Buccollini, Lynn E Delis. A controlled family study of cannabis users with and without psychosis. Schizophrenia research. vol 152. issue 1. 2014-08-29. PMID:24309013. |
the present study aims to determine whether familial morbid risk for schizophrenia is the crucial factor that underlies the association of adolescent cannabis use with the development of schizophrenia. |
2014-08-29 |
2023-08-12 |
Not clear |
| Mary V Seeman, Philip Seema. Is schizophrenia a dopamine supersensitivity psychotic reaction? Progress in neuro-psychopharmacology & biological psychiatry. vol 48. 2014-08-01. PMID:24128684. |
today, we have evidence that gene mutations, brain injury, drug use (cocaine, amphetamine, marijuana, phencyclidine, and steroids), prenatal infection and malnutrition, social isolation and marginalization, can all result in the signs and symptoms of schizophrenia. |
2014-08-01 |
2023-08-12 |
human |
| Kim R De Sousa, Arun K Tiwari, Daniel E Giuffra, Bronwyn Mackenzie, Clement C Zai, James L Kenned. Age at onset of schizophrenia: cannabis, COMT gene, and their interactions. Schizophrenia research. vol 151. issue 1-3. 2014-07-29. PMID:24268936. |
age at onset of schizophrenia: cannabis, comt gene, and their interactions. |
2014-07-29 |
2023-08-12 |
Not clear |
| Evan Leibu, Amir Garakani, Daniel P McGonigle, Lauren S Liebman, Daniella Loh, Ethan O Bryson, Charles H Kellne. Electroconvulsive therapy (ECT) for catatonia in a patient with schizophrenia and synthetic cannabinoid abuse: a case report. The journal of ECT. vol 29. issue 4. 2014-07-17. PMID:23670023. |
we present the case of a young man with a long-standing history of schizophrenia who presented with severe and life-threatening catatonia in the setting of synthetic cannabis use who was successfully treated with electroconvulsive therapy. |
2014-07-17 |
2023-08-12 |
Not clear |
| Jonathan K Burn. Pathways from cannabis to psychosis: a review of the evidence. Frontiers in psychiatry. vol 4. 2014-06-24. PMID:24133460. |
researchers and clinicians remain divided regarding key issues such as whether or not cannabis is an independent cause of psychosis and schizophrenia. |
2014-06-24 |
2023-08-12 |
Not clear |
| Benjamin Chadwick, Michael L Miller, Yasmin L Hur. Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness. Frontiers in psychiatry. vol 4. 2014-06-24. PMID:24133461. |
a strong association between schizophrenia and cannabis use is also apparent, especially when considering genetic factors that interact with this environmental exposure. |
2014-06-24 |
2023-08-12 |
human |
| Amresh Shrivastava, Megan Johnston, Kristen Terpstra, Yves Burea. Cannabis and psychosis: Neurobiology. Indian journal of psychiatry. vol 56. issue 1. 2014-06-24. PMID:24574553. |
we examine the neurobiological changes due to cannabis to see if these changes are similar to those seen in schizophrenic patients the findings show similarities; however, these mere similarities cannot establish a 'cause-effect' relationship as a number of people with similar changes do not develop schizophrenia. |
2014-06-24 |
2023-08-12 |
Not clear |
| Amresh Shrivastava, Megan Johnston, Kristen Terpstra, Yves Burea. Cannabis and psychosis: Neurobiology. Indian journal of psychiatry. vol 56. issue 1. 2014-06-24. PMID:24574553. |
major advances have been made in understanding the underpinning of marijuana dependence, and the role of the cannabinoid system, which is a major area for targeting medications to treat marijuana withdrawal and dependence, as well as other addictions is of now, it is clear that some of the similarities in the neurobiology of cannabis and schizophrenia may indicate a mechanism for the development of psychosis, but its trajectories are undetermined. |
2014-06-24 |
2023-08-12 |
Not clear |
| Rajiv Radhakrishnan, Samuel T Wilkinson, Deepak Cyril D'Souz. Gone to Pot - A Review of the Association between Cannabis and Psychosis. Frontiers in psychiatry. vol 5. 2014-06-24. PMID:24904437. |
emerging evidence supports a number of associations between cannabis and psychosis/psychotic disorders, including schizophrenia. |
2014-06-24 |
2023-08-13 |
Not clear |
| Rajiv Radhakrishnan, Samuel T Wilkinson, Deepak Cyril D'Souz. Gone to Pot - A Review of the Association between Cannabis and Psychosis. Frontiers in psychiatry. vol 5. 2014-06-24. PMID:24904437. |
acute exposure to both cannabis and synthetic cannabinoids (spice/k2) can produce a full range of transient psychotomimetic symptoms, cognitive deficits, and psychophysiological abnormalities that bear a striking resemblance to symptoms of schizophrenia. |
2014-06-24 |
2023-08-13 |
Not clear |
| Rajiv Radhakrishnan, Samuel T Wilkinson, Deepak Cyril D'Souz. Gone to Pot - A Review of the Association between Cannabis and Psychosis. Frontiers in psychiatry. vol 5. 2014-06-24. PMID:24904437. |
the relationship between cannabis and schizophrenia fulfills many but not all of the standard criteria for causality, including temporality, biological gradient, biological plausibility, experimental evidence, consistency, and coherence. |
2014-06-24 |
2023-08-13 |
Not clear |
| H Bugra, E Studerus, C Rapp, C Tamagni, J Aston, S Borgwardt, A Riecher-Rössle. Cannabis use and cognitive functions in at-risk mental state and first episode psychosis. Psychopharmacology. vol 230. issue 2. 2014-06-23. PMID:23756588. |
meta-analyses suggest that schizophrenia patients with a history of cannabis use have less impaired cognitive functioning compared to patients without cannabis use. |
2014-06-23 |
2023-08-12 |
Not clear |
| Grant E Sara, Philip M Burgess, Gin S Malhi, Harvey A Whiteford, Wayne C Hal. The impact of cannabis and stimulant disorders on diagnostic stability in psychosis. The Journal of clinical psychiatry. vol 75. issue 4. 2014-06-23. PMID:24813404. |
this study examined whether comorbid substance disorder was associated with diagnostic instability and progression from other psychosis diagnoses to schizophrenia and whether effects differed for cannabis and stimulant-related disorders. |
2014-06-23 |
2023-08-13 |
Not clear |
| Maju Mathew Koola, Douglas Lee Boggs, Deanna Lynn Kelly, Fang Liu, Jared Allen Linthicum, Hailey Elaine Turner, Robert Patrick McMahon, David Alan Gorelic. Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. Psychiatry research. vol 209. issue 3. 2014-05-30. PMID:23969281. |
relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. |
2014-05-30 |
2023-08-12 |
human |
| Maju Mathew Koola, Douglas Lee Boggs, Deanna Lynn Kelly, Fang Liu, Jared Allen Linthicum, Hailey Elaine Turner, Robert Patrick McMahon, David Alan Gorelic. Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. Psychiatry research. vol 209. issue 3. 2014-05-30. PMID:23969281. |
this study examined the response to cannabis withdrawal symptoms and use of quitting strategies to maintain abstinence in people with schizophrenia. |
2014-05-30 |
2023-08-12 |
human |
| Maju Mathew Koola, Douglas Lee Boggs, Deanna Lynn Kelly, Fang Liu, Jared Allen Linthicum, Hailey Elaine Turner, Robert Patrick McMahon, David Alan Gorelic. Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. Psychiatry research. vol 209. issue 3. 2014-05-30. PMID:23969281. |
a convenience sample of 120 participants with schizophrenia who had at least weekly cannabis use and a previous quit attempt without formal treatment were administered the 176-item marijuana quit questionnaire to characterize their "most serious" (self-defined) quit attempt. |
2014-05-30 |
2023-08-12 |
human |